Symptomatic treatment of cancer-related anaemia involves blood transfusions and/or erythropoietic agents

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.5, 2006-05, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epoetin alfa improves QOL in cancer-related anaemia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 251, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Epoetin alfa improves QOL in cancer-related anaemia

Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Prevention and Treatment of Cancer-Related Infections

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 122-122

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Balancing act required when considering ESAs for cancer-related anaemia

Reactions Weekly, Vol. 1, Iss. 1251, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Role of Erythropoietin in Cancer-related Anaemia: a Double-edged Sword?

By Guan X Chen L

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 1-8

Field House Publishing

Access to resources Recommend Favorite